RadiDoseControl Portfolio | Acquisition Opportunity

RadiDoseControl Patent Portfolio

Precision ownership
of radiation delivery

A defensible, system-level patent portfolio enabling precise control over how radiation is delivered inside the human body across modern oncology procedures. Developed by Dr. Mark D'Andrea.

7 US Patents Granted
7 International Assets
Active Prosecution

This portfolio controls the delivery layer of radiation therapy. In a field where precision defines outcomes, ownership of how radiation is deployed is no longer optional. It is strategic. Five technology families. Fourteen assets. One coherent clinical platform spanning diagnosis, positioning, and treatment delivery across gynecological, intracavitary, and body surface indications.

14
Total Patent Assets
7
US Grants
5
Technology Families
3
Jurisdictions

Seven granted patents.
Five technology families.

US 8,979,725

Brachytherapy tandem and ovoid implantation — the foundational system-level asset covering intracavitary radiation placement with a detachable distal section.

Tandem & Ovoid Family
US 9,320,915

Continuation extending protection for tandem and ovoid implantation techniques. Terminal disclaimer linked to parent patent.

Tandem & Ovoid Family
US 9,149,653

Multi-site balloon catheter enabling simultaneous radiation delivery across multiple intracavitary treatment sites in a single procedure.

Multi-Site Catheter
US 9,192,345

Diagnostic mapping and marking system with movable spoke-mounted detectors for real-time positioning intelligence before and during treatment.

Diagnostic Mapping
US 9,604,074

Flexible sheet radiation treatment devices for sarcomas and body surface indications — conformable to limbs, surgically exposed cavities, and retroperitoneal sites.

Sheet Device Family
US 10,207,127

Continuation extending sheet device protection with refined claim architecture covering the full surface treatment and hyperthermia combination workflow.

Sheet Device Family
US 10,086,213

Mobile gynecological balloon device sliding longitudinally along a tandem and positioning by inflation — with cervix-conforming distal ring and detachable single-use distal section.

Mobile Balloon

Canada & Mexico.
Granted, allowed, and pending.

CA 2,874,228

Granted. Brachytherapy tandem and ovoid implantation systems for the Canadian market.

Canada · Granted
CA 2,902,707

Pending. Radiation delivery method improvements.

Canada · Pending
CA 2,904,896

Pending. Radiation diagnosis and treatment systems.

Canada · Pending
CA 2,846,715

Pending. Sheet technology for body surface radiation treatment.

Canada · Pending
MX/a/2015/011519

Allowed. Therapeutic radiation delivery systems for the Mexican market.

Mexico · Allowed
MX/a/2015/011524

Pending. Radiation diagnosis systems.

Mexico · Pending
MX/a/2014/003102

Allowed. Radiation sheet technology for the Mexican market.

Mexico · Allowed

A rare opportunity to acquire control over a critical layer of oncology treatment infrastructure.

Contact for Acquisition Discussions

Managed by Aveli Consulting  ·  [email protected]

RadiDoseControl  ·  ~  ·  © 2026 Aveli Consulting